Skip to main content
Market intelligence
PTHSSector not reported

Pelthos Therapeutics Inc. insider activity

In the last 90 days, 1 corporate insider purchased $999,983 of stock on the open market.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$999,983
Corporate buyers
1
Latest transaction
Jun 15, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Jun 15, 2026Ezra M FriedbergCorporate insiderSale283$27.29$7,724
Jun 11, 2026Todd C DavisCorporate insiderOpen Market Purchase35,948$27.82$999,983
May 22, 2026Knuettel Francis IiCFO, Treas & SectySale1,500$26.84$40,265